Advertisement

Social factors in marijuana use for medical and recreational purposes

Published:January 26, 2017DOI:https://doi.org/10.1016/j.yebeh.2016.11.011

      Highlights

      • A sociological framework for conceptualizing cannabis use in the US is presented.
      • The evolution of the sociocultural perspectives on cannabis use is explored.
      • Trends in cannabis use for recreational/medical use and public views are reviewed.
      • Current policy, legal, and economic issues are discussed.
      • Directions for research on social factors in cannabis use in epilepsy are outlined.

      Abstract

      Of all the various treatment options for epilepsy, no other therapy comes close to the polarity that cannabis engenders. The rationale for this reaction is firmly rooted in the social factors that enshroud the use of marijuana for both medical and recreational purposes. In order to best understand how to approach this controversial treatment, it is essential to explore the social, demographic, and historical variables that have led to the current opinions on cannabis therapy and how this has converged on epilepsy treatment. Utilizing a sociological conceptual framework, this review discusses in depth the social, cultural, and historical dimensions of cannabis use in the US for medical purposes and its impact on epilepsy treatment. Moreover, it posits that cannabis therapy and the opinions surrounding its use are products of history and assesses this treatment option through the lens of our current times.
      This article is part of a Special Issue titled Cannabinoids and Epilepsy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Epilepsy & Behavior
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Pearce D.D.
        • Mitsouras K.
        • Irizarry K.J.
        Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users.
        J Altern Complement Med. 2014; 20: 787-791
        • Substance Abuse and Mental Health Services Administration (SAMHSA)
        Marijuana (Cannabis).
        ([Accessed September 6, 2016])
        • Azofeifa A.
        • Mattson M.E.
        • Schauer G.
        • McAfee T.
        • Grant A.
        • Lyerla R.
        National estimates of marijuana use and related indicators — National Survey on Drug Use and Health, United States, 2002–2014.
        MMWR Morb Mortal Wkly Rep. 2016; 65: 1-25
        • Szaflarski J.P.
        • Bebin E.M.
        Cannabis, cannabidiol, and epilepsy–from receptors to clinical response.
        Epilepsy Behav. 2014; 41: 277-282
        • Schrot R.J.
        • Hubbard J.R.
        Cannabinoids: medical implications.
        Ann Med. 2016; 48: 128-141
        • Volkow N.D.
        • Baler R.D.
        Foreword. Substance use and abuse among adolescents.
        Adolesc Med State Art Rev. 2014; 25 (xv–xvi)
        • Volkow N.D.
        • Baler R.D.
        • Compton W.M.
        • Weiss S.R.
        Adverse health effects of marijuana use.
        N Engl J Med. 2014; 370: 2219-2227
        • Ranieri R.
        • Laezza C.
        • Bifulco M.
        • Marasco D.
        • Malfitano A.M.
        Endocannabionoid system in neurological disorders.
        Recent Pat CNS Drug Discov. 2016; 10: 90-112
        • Hussain S.A.
        • Zhou R.
        • Jacobson C.
        • Weng J.
        • Cheng E.
        • Lay J.
        • et al.
        Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: a potential role for infantile spasms and Lennox-Gastaut syndrome.
        Epilepsy Behav. 2015; 47: 138-141
        • Lipiello P.
        • Balestrini S.
        • Leo A.
        • Coppola A.
        • Citraro R.
        • Eila M.
        • et al.
        From cannabis to cannabidiol to treat epilepsy, where are we?.
        Curr Pharm Des. 2016 Aug 31; 22 (PMID: 27587196 [Epub ahead of print])https://doi.org/10.2174/1381612822666160831122722
        • Porter B.E.
        • Jacobson C.
        Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.
        Epilepsy Behav. 2013; 29: 574-577
        • Sirven J.I.
        Cannabis, cannabidiol, and epilepsies: the truth is somewhere in the middle.
        Epilepsy Behav. 2014; 41: 270-271
        • Grant I.
        • Atkinson J.H.
        • Gouaux B.
        Research on medical marijuana.
        Am J Psychiatry. 2012; 169: 1119-1120
        • Cockerham W.C.
        Social causes of health and disease.
        Polity Press, Malden, MA2013
        • Gabe J.
        • Bury M.
        • Elston M.A.
        Key concepts in medical sociology.
        Sage, London2004
        • Acevedo B.
        Creating the cannabis user. A post-structuralist analysis of the re-classification of cannabis in the United Kingdom (2004–2005).
        Int J Drug Policy. 2007; 18: 177-186
        • Reinarman C.
        Addiction as accomplishment: the discursive construction of disease.
        Addict Res Theory. 2005; 13: 307-320
        • Becker H.S.
        Outsiders: studies in the sociology of deviance.
        The Free Press, New York1963
        • Faupel C.E.
        • Weaver G.
        • Corzine J.
        The sociology of American drug use.
        3rd ed. Oxford University Press, New York2014
        • Conrad P.
        The discovery of hyperkinesis: notes on the medicalization of deviant behavior.
        Soc Probl. 1975; 23: 12-21
        • Herman R.S.
        • Einhorn L.H.
        • Jones S.E.
        • Nagy C.
        • Chester A.B.
        • Dean J.C.
        • et al.
        Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
        N Engl J Med. 1979; 300: 1295-1297
        • Szaflarski M.
        • Vaughn L.M.
        Deconstructing and addressing health disparities to build health equity.
        in: Murray M. Critical health psychology. 2nd ed. Palgrave Macmillan, New York, NY2014: 87-107
        • Szaflarski M.
        Social determinants of health in epilepsy.
        Epilepsy Behav. 2014; 41: 283-289
        • Solar O.
        • Irwin A.
        A conceptual framework for action on the social determinants of health. (discussion paper series on social determinants of health, 2).
        World Health Organization, Geneva, Switzerland2010 ([http://whqlibdoc.who.int/publications/2010/9789241500852_eng.pdf. Accessed 2 December 2013])
        • Deitch R.
        American history revisited.
        Alegoria, New York City2003
        • Demby G.
        The many different faces of marijuana in America.
        2013
        • Institute of Medicine
        Joy J.E. Watson Jr., S.J. Benson Jr., J.A. Marijuana and medicine: assessing the science base. Institute of Medicine, Washington (DC)1999
        • Caulkins J.P.
        • Lee M.A.C.
        • Kasunic A.M.
        Marijuana legalization: lessons from the 2012 state proposals.
        World Med Health Policy. 2012; 4: 4-34
        • Ferraiolo K.
        Morality framing in U.S. drug control policy: an example from marijuana decriminalization.
        World Med Health Policy. 2014; 6: 347-374
        • Rubens M.
        Political and medical views on medical marijuana and its future.
        Soc Work Public Health. 2014; 29: 121-131
        • Bostwick J.M.
        Blurred boundaries: the therapeutics and politics of medical marijuana.
        Mayo Clin Proc. 2012; 87: 172-186
        • National Conference of State Legislatures
        State medical marijuana laws.
        ([Accessed September 9, 2016])
        • Bestrashniy J.
        • Winters K.C.
        Variability in medical marijuana laws in the United States.
        Psychol Addict Behav. 2015; 29: 639-642
        • Hasin D.S.
        • Wall M.
        • Keyes K.M.
        • Cerdá M.
        • Schulenberg J.
        • O'Malley P.M.
        • et al.
        Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys.
        Lancet Psychiatry. 2015; 2: 601-608
        • Lynne-Landsman S.D.
        • Livingston M.D.
        • Wagenaar A.C.
        Effects of state medical marijuana laws on adolescent marijuana use.
        Am J Public Health. 2013; 103: 1500-1506
        • Stolzenberg L.
        • D'Alessio S.J.
        • Dariano D.
        The effect of medical cannabis laws on juvenile cannabis use.
        Int J Drug Policy. 2016; 27: 82-88
        • Garland D.
        The culture of control: crime and social order in contemporary society.
        Chicago Press, Chicago, IL2001
        • O'Brien P.K.
        Medical marijuana and social control: escaping criminalization and embracing medicalization.
        Deviant Behav. 2013; 34: 423-443
        • Geiger A.
        Support for marijuana legalization continues to rise.
        ([Accessed 12 October 2016])
        • Boggess L.N.
        • Pérez D.M.
        • Cope K.
        • Root C.
        • Stretesky P.B.
        Do medical marijuana centers behave like locally undesirable land uses? Implications for the geography of health and environmental justice.
        Urban Geogr. 2014; 35: 315-336
        • Salkin P.
        • Kansler Z.
        Medical marijuana meets zoning: can you grow, sell, and smoke that here?.
        Planning & Environmental Law. 2010; 62: 3-8
        • Nemeth J.
        • Ross E.
        Planning for marijuana: the cannabis conondrum.
        J Am Plann Assoc. 2014; 80: 6-20
        • Morrison C.
        • Gruenewald P.J.
        • Freisthler B.
        • Ponicki W.R.
        • Remer L.G.
        The economic geography of medical cannabis dispensaries in California.
        Int J Drug Policy. 2014; 25: 508-515
        • Hanson K.
        Regulating marijuana: Taxes, banking and federal laws.
        in: National Conference of State Legislatures LegisBrief. 2015: 23(43)
        • Okaneku J.
        • Vearrier D.
        • McKeever R.G.
        • Lasala G.S.
        • Greenberg M.I.
        Change in perceived risk associated with marijuana use in the United States from 2002 to 2012.
        Clin Toxicol. 2015; 53: 151-155
        • Pacek L.R.
        • Mauro P.M.
        • Martins S.S.
        Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race/ethnicity.
        Drug Alcohol Depend. 2015; 149: 232-244
        • Johnston L.D.
        • O'Malley P.M.
        • Miech R.A.
        • Bachman J.G.
        • Schulenberg J.E.
        Monitoring the future: national survey results on drug use 1975–2014: overview, key findings on adolescent drug use.
        Institute for Social Research, The University of Michigan, Ann Arbor, MI2015
        • Fairman B.J.
        Trends in registered medical marijuana participation across 13 US states and District of Columbia.
        Drug Alcohol Depend. 2016; 159: 72-79
      1. Golub A.L. The cultural/subcultural contexts of marijuana use at the turn of the twenty-first century. Haworth, New York2005
        • Kelly B.C.
        Bongs and blunts: notes from a suburban marijuana subculture.
        in: Golub A.L. The cultural/subcultural contexts of marijuana use at the turn of the twenty-first century. Haworth, New York2005: 81-98
        • MacKenzie K.
        • Hunt G.
        • Joe-Laidler K.
        Youth gangs and drugs: the case of marijuana.
        in: Golub A.L. The cultural/subcultural contexts of marijuana use at the turn of the twenty-first century. Haworth, New York2005: 99-134
        • Chapkis W.
        • Webb R.J.
        Mother's milk and the muffin man: grassroots innovations in medical marijuana delivery methods.
        in: Golub A.L. The cultural/subcultural contexts of marijuana use at the turn of the twenty-first century. Haworth, New York2005: 183-204
        • Gupta S.D.
        Sanjay Gupta: it's time for a medical marijuana revolution. CNN.
        ([Accessed October 25, 2016])
        • Maa E.
        • Figi P.
        The case for medical marijuana in epilepsy.
        Epilepsia. 2014; 55: 783-786
        • Sirven J.I.
        • Shafer P.O.
        Medical marijuana and epilepsy.
        ([Accessed October 23, 2016])
        • Epilepsy Foundation
        2016 Government Affairs Statement.
        ([Accessed October 24, 2016])
        • Epilepsy Foundation
        2016 Epilepsy Capitol Hill Message.
        ([Accessed October 24, 2016])
        • Fuller T.
        Election may be a turning point for legal marijuana. The New York Times.
        ([Accessed October 24, 2016])
        • Berman H.
        Legalizing marijuana. The New York Times.
        ([Accessed October 24, 2016])